Pfizer triumphs over Novo Nordisk with $10B bid for Metsera
辉瑞以100亿美元收购要约击败诺和诺德，赢得Metsera

Pfizer has won the bidding war for the obesity drug developer Metsera. The biotech accepted an increased bid from the New York pharma worth a total of $10 billion.
辉瑞在收购战中击败竞争对手，赢得了肥胖症药物开发商Metsera。该生物科技公司接受了来自New York pharma的加价收购要约，总对价为100亿美元。